Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytoma.
Tripathi S, Najem H, Dussold C, Pacheco S, Du R, Sooreshjani M, Hurley L, Chandler JP, Stupp R, Sonabend AM, Horbinski CM, Lukas RV, Xiu J, Lopez G, Nicolaides TP, Brown V, Wadhwani NR, Lam SK, James CD, Rao G, Castro MG, Heimberger AB, DeCuypere M.
Tripathi S, et al. Among authors: rao g.
J Clin Invest. 2024 Aug 13;134(19):e177413. doi: 10.1172/JCI177413.
J Clin Invest. 2024.
PMID: 39137048
Free PMC article.